Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Comparison of desipramine and cognitive/behavioral therapy in the treatment of elderly outpatients with mild-to-moderate depression.

Thompson LW, Coon DW, Gallagher-Thompson D, Sommer BR, Koin D.

Am J Geriatr Psychiatry. 2001 Summer;9(3):225-40.

PMID:
11481130
2.
3.

Nonsomatic treatment of depression.

Sherrill JT, Kovacs M.

Child Adolesc Psychiatr Clin N Am. 2002 Jul;11(3):579-93. Review.

PMID:
12222084
4.

A randomised controlled trial of cognitive behaviour therapy vs treatment as usual in the treatment of mild to moderate late life depression.

Laidlaw K, Davidson K, Toner H, Jackson G, Clark S, Law J, Howley M, Bowie G, Connery H, Cross S.

Int J Geriatr Psychiatry. 2008 Aug;23(8):843-50. doi: 10.1002/gps.1993.

PMID:
18311844
5.

Cognitive therapy vs medications in the treatment of moderate to severe depression.

DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, O'Reardon JP, Lovett ML, Gladis MM, Brown LL, Gallop R.

Arch Gen Psychiatry. 2005 Apr;62(4):409-16.

PMID:
15809408
6.

A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.

Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.

Health Technol Assess. 2008 May;12(14):iii-iv, ix-60.

7.

A comparison of cognitive-behavioral therapy, sertraline, and their combination for adolescent depression.

Melvin GA, Tonge BJ, King NJ, Heyne D, Gordon MS, Klimkeit E.

J Am Acad Child Adolesc Psychiatry. 2006 Oct;45(10):1151-61.

PMID:
17003660
8.

Clinical effectiveness of individual cognitive behavioral therapy for depressed older people in primary care: a randomized controlled trial.

Serfaty MA, Haworth D, Blanchard M, Buszewicz M, Murad S, King M.

Arch Gen Psychiatry. 2009 Dec;66(12):1332-40. doi: 10.1001/archgenpsychiatry.2009.165.

PMID:
19996038
9.

Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).

Curry J, Rohde P, Simons A, Silva S, Vitiello B, Kratochvil C, Reinecke M, Feeny N, Wells K, Pathak S, Weller E, Rosenberg D, Kennard B, Robins M, Ginsburg G, March J; TADS Team..

J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1427-39.

PMID:
17135988
10.

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.

March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J.

Arch Gen Psychiatry. 2007 Oct;64(10):1132-43. Erratum in: Arch Gen Psychiatry. 2008 Jan;65(1):101.

PMID:
17909125
11.

A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.

Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S, Lewison B, Goodkin R, Lawson K, Lawson D, Evans DL, Nemeroff CB.

J Clin Psychiatry. 2006 Feb;67(2):288-96.

PMID:
16566626
12.

Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression.

Dimidjian S, Hollon SD, Dobson KS, Schmaling KB, Kohlenberg RJ, Addis ME, Gallop R, McGlinchey JB, Markley DK, Gollan JK, Atkins DC, Dunner DL, Jacobson NS.

J Consult Clin Psychol. 2006 Aug;74(4):658-70.

PMID:
16881773
13.

Does adding psychotherapy to pharmacotherapy improve social functioning in the treatment of outpatient depression?

Molenaar PJ, Dekker J, Van R, Hendriksen M, Vink A, Schoevers RA.

Depress Anxiety. 2007;24(8):553-62.

PMID:
17131302
14.
15.

The effect of psychotherapy added to pharmacotherapy on cortisol responses in outpatients with major depressive disorder.

Yang TT, Hsiao FH, Wang KC, Ng SM, Ho RT, Chan CL, Lai YM, Chen YT.

J Nerv Ment Dis. 2009 Jun;197(6):401-6. doi: 10.1097/NMD.0b013e3181a61594.

PMID:
19525739
16.

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders.

Drossman DA, Toner BB, Whitehead WE, Diamant NE, Dalton CB, Duncan S, Emmott S, Proffitt V, Akman D, Frusciante K, Le T, Meyer K, Bradshaw B, Mikula K, Morris CB, Blackman CJ, Hu Y, Jia H, Li JZ, Koch GG, Bangdiwala SI.

Gastroenterology. 2003 Jul;125(1):19-31.

PMID:
12851867
17.

Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.

McDowell D, Nunes EV, Seracini AM, Rothenberg J, Vosburg SK, Ma GJ, Petkova E.

Drug Alcohol Depend. 2005 Nov 1;80(2):209-21.

PMID:
15913920
18.

One-year follow-up of psychosocial and pharmacologic treatments for bulimia nervosa.

Agras WS, Rossiter EM, Arnow B, Telch CF, Raeburn SD, Bruce B, Koran LM.

J Clin Psychiatry. 1994 May;55(5):179-83.

PMID:
8071266
19.

Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment?

Hollon SD, Jarrett RB, Nierenberg AA, Thase ME, Trivedi M, Rush AJ.

J Clin Psychiatry. 2005 Apr;66(4):455-68. Review.

PMID:
15816788
20.

Management of depression in rheumatoid arthritis: a combined pharmacologic and cognitive-behavioral approach.

Parker JC, Smarr KL, Slaughter JR, Johnston SK, Priesmeyer ML, Hanson KD, Johnson GE, Hewett JE, Hewett JE, Irvin WS, Komatireddy GR, Walker SE.

Arthritis Rheum. 2003 Dec 15;49(6):766-77.

Items per page

Supplemental Content

Support Center